Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection
Overview of attention for article published in JAIDS: Journal of Acquired Immune Deficiency Syndromes, October 2004
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
High Attention Score compared to outputs of the same age and source (85th percentile)
Readers on
- mendeley
- 97 Mendeley